Validation of Optimal Ampicillin/Sulbactam Ratio in Dosage Forms Using In-Vitro Dynamic Model
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 14 (15-17) , 2425-2442
- https://doi.org/10.3109/03639048809152025
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Antibacterial activity of ticarcillin in the presence of clavulanate potassiumThe American Journal of Medicine, 1985
- Clinical pharmacology and safety evaluation of timentinThe American Journal of Medicine, 1985
- Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic modelsJournal of Antimicrobial Chemotherapy, 1985
- Historical review of in-vitro modelsJournal of Antimicrobial Chemotherapy, 1985
- Amoxicillin and Potassium Clavulanate: An Antibiotic Combination Mechanism of Action, Pharmacokinetics, Antimicrobial Spectrum, Clinical Efficacy and Adverse EffectsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
- Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatographyJournal of Antimicrobial Chemotherapy, 1983
- A test and calibration process for microcalorimeters used a thermal power metersJournal of Biochemical and Biophysical Methods, 1982
- Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administrationAntimicrobial Agents and Chemotherapy, 1982
- New in vitro kinetic model for evaluating bactericidal efficacy of antibioticsAntimicrobial Agents and Chemotherapy, 1980